DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TOPROL-XL

« Back to Dashboard

All Clinical Trials for Toprol-xl

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00038077	Reversal of Ventricular Remodeling With Toprol-XL	Completed	AstraZeneca	Phase 3	2001-08-01	The purpose of this study is to determine whether treatment with Toprol-XL for 12 months in asymptomatic heart failure subjects will improve their heart structure and thus prevent the progression to symptomatic disease.
NCT00123903	COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria	Terminated	GlaxoSmithKline	Phase 3	2005-07-01	This study was designed to determine whether COREG MR is more effective than TOPROL-XL in reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood pressure and microalbuminuria.
NCT00241904	Reducing Total Cardiovascular Risk in an Urban Community	Completed	National Heart, Lung, and Blood Institute (NHLBI)	N/A	2006-05-01	PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
NCT00241904	Reducing Total Cardiovascular Risk in an Urban Community	Completed	Johns Hopkins University	N/A	2006-05-01	PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.

Clinical Trial Conditions for Toprol-xl

Condition Name

Condition Name for Toprol-xl
Intervention	Trials
Hypertension	8
Fasting	2
Diabetes Mellitus	2
Healthy	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Toprol-xl
Intervention	Trials
Hypertension	8
Heart Failure	4
Diabetes Mellitus	2
Atrial Fibrillation	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Toprol-xl

Trials by Country

Trials by Country for Toprol-xl
Location	Trials
United States	128
Canada	12
India	5
Dominican Republic	2
Puerto Rico	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Toprol-xl
Location	Trials
Florida	8
Pennsylvania	7
Ohio	7
New York	7
California	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Toprol-xl

Clinical Trial Phase

Clinical Trial Phase for Toprol-xl
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	7
Phase 2	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Toprol-xl
Clinical Trial Phase	Trials
Completed	15
Unknown status	3
Recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Toprol-xl

Sponsor Name

Sponsor Name for Toprol-xl
Sponsor	Trials
AstraZeneca	4
IPCA Laboratories Ltd.	3
Dr. Reddy's Laboratories Limited	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Toprol-xl
Sponsor	Trials
Industry	18
Other	11
NIH	2

Export unavailable in trial.
Subscribe for complete access.